Skip to main content
Home/Biomarkers/Total Testosterone
HORMONE BIOMARKER

Total Testosterone

Total Testosterone

The most commonly measured hormone in men - but rarely the most informative without the context of SHBG and free testosterone.

STANDARD RANGE
264–916 ng/dL (adult males, US lab convention)
OPTIMAL (OPTIMIZATION)
500–900 ng/dL is a common target in optimization practice
RANGE VISUALIZATION

How Total Testosterone ranges relate

The standard lab range vs the optimization-focused target. Illustrative trajectory shows what a 12-week improvement pattern looks like — not real user data.

264916STANDARD LAB RANGEOPTIMALWK 0WK 12ILLUSTRATIVE TRAJECTORY (NOT REAL DATA)
Standard lab rangeOptimization-focused targetIllustrative trajectory
TRACKED IN PROTOCOLS FOR
Build MuscleLibido & Sexual Health

What Total Testosterone Measures

Total testosterone measures all testosterone in circulation - both the free (bioavailable) fraction and the much larger fraction bound to carrier proteins, primarily SHBG (sex hormone binding globulin) and albumin. For most clinical decisions, total testosterone is the starting point, but it is an incomplete picture in isolation. Two men with identical total testosterone can have very different free testosterone values depending on SHBG - and free testosterone is what tissues actually use.

Total testosterone shows meaningful diurnal variation, peaking in the early morning (7–10 AM) and dropping 30–50% by evening. Reference labs draw in the morning window for this reason. Values also respond to acute factors: illness, poor sleep, intensive training, and recent alcohol all transiently depress testosterone.

What Affects This Biomarker

Total testosterone is influenced by: age (declines ~1% per year after 30), body composition (visceral fat lowers testosterone via aromatization), sleep quality (deep sleep is where most testosterone is produced), training load (overtraining suppresses; moderate training supports), insulin resistance, opioids, alcohol, head/testicular trauma, and pharmacologic agents - TRT, enclomiphene, clomiphene, HCG, aromatase inhibitors. Hypogonadism can be primary (testicular), secondary (pituitary/hypothalamic), or mixed.

In the Context of Peptide Protocols

For TRT, enclomiphene, or HCG users, total testosterone is tracked at baseline and at 6–8 weeks post-initiation to assess response. The follow-up timing and draw conditions matter - morning draws, post-injection timing standardized (typically mid-cycle for cypionate users). Because total testosterone alone can mislead, any serious optimization protocol will pull total + free + SHBG + estradiol together. Peptide protocols (particularly kisspeptin, enclomiphene, and HCG-inclusive stacks) can substantially alter the axis and warrant full-panel tracking.

Related Reading

Conditions That Track Total Testosterone

HORMONAL
Low Testosterone
The cluster of symptoms and lab findings users discuss with their provider when testosterone levels trend low.
RECOVERY
Poor Sleep Quality
Chronic insufficient or fragmented sleep - upstream of most metabolic, hormonal, and cognitive markers.
RECOVERY
Chronic Fatigue / Low Energy
Persistent unexplained fatigue - always requires a clinician workup. Tracked patterns give context to those conversations.
RECOVERY
Poor Recovery / Overtraining
The pattern users see when training load exceeds recovery capacity - trackable via HRV, RHR, and specific biomarkers.
HORMONAL
Andropause (Age-Related Testosterone Decline)
The gradual age-related decline in testosterone (~1% per year after 30) and the cluster of symptoms that sometimes accompanies it.
Track Total Testosterone over time.

Upload any lab PDF and MyProtocolStack maps your values to Total Testosterone and 40+ other biomarkers. StackAI interprets the trend in context of your protocol.

Start tracking →

Informational only - not medical advice. Reference ranges vary by lab and individual context. Work with a licensed provider to interpret your specific results.